This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
What were the billion-dollar small molecules in 2021? This article and infographic, which is part 3 of a Premium series…
Article
1 year ago ●
2 mins read
An old molecule and an old target come together. Squalamine was originally discovered in 1993 as an antimicrobial from the…
molecule
9 months ago ●
3 mins read
What were the billion-dollar large molecules in 2021? This article and infographic, which is part 4 of a Premium series…
Article
1 year ago ●
3 mins read
The first approved EGFR exon 20 mutant inhibitor. While there are now three generations of EGFR inhibitors approved, patients harboring…
molecule
9 months ago ●
6 mins read
This article and infographic highlights the drug discovery biotech acquisitions of 2021 where the upfront payment was disclosed, along with…
Article
1 year ago ●
3 mins read
Overcoming FGFR mutation resistance and FGFR1-mediated hyperphosphatemia toxicity through isoform-selective FGFR2/3 inhibition. “Compound 29” is an ATP-competitive fibroblast growth factor…
molecule
9 months ago ●
3 mins read
Load More
